» Articles » PMID: 26989766

Novel Impact of EWI-2, CD9, and CD81 on TGF-β Signaling in Melanoma

Overview
Journal Mol Cell Oncol
Specialty Oncology
Date 2016 Mar 19
PMID 26989766
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Cell surface transmembrane protein IGFS8 (herein called EWI-2) negatively regulates melanoma TGF-β signaling and is well positioned to control the transition in TGF-β signaling from cytostatic (in early melanoma stages) to pro-invasion/metastasis (in later stages). EWI-2 functions by sequestering the tetraspanin proteins CD9 and CD81, thereby making them unavailable to support the association of TGFβ receptor 1 with TGFβ receptor 2.

Citing Articles

TGF-β induces cholesterol accumulation to regulate the secretion of tumor-derived extracellular vesicles.

Rodrigues-Junior D, Tsirigoti C, Psatha K, Kletsas D, Aivaliotis M, Heldin C J Exp Clin Cancer Res. 2025; 44(1):42.

PMID: 39910665 PMC: 11800471. DOI: 10.1186/s13046-025-03291-0.


Differential effects of sugar and fat on adipose tissue inflammation.

Avequin T, Lau K, Waldhart A, Guak H, Dykstra H, Krawczyk C iScience. 2023; 26(7):107163.

PMID: 37456843 PMC: 10338233. DOI: 10.1016/j.isci.2023.107163.


Targeting of Tetraspanin CD81 with Monoclonal Antibodies and Small Molecules to Combat Cancers and Viral Diseases.

Bailly C, Thuru X Cancers (Basel). 2023; 15(7).

PMID: 37046846 PMC: 10093296. DOI: 10.3390/cancers15072186.


EWI2 promotes endolysosome-mediated turnover of growth factor receptors and integrins to suppress lung cancer.

Wang J, Wren J, Ding Y, Chen J, Mittal N, Xu C Cancer Lett. 2022; 536:215641.

PMID: 35339615 PMC: 9036562. DOI: 10.1016/j.canlet.2022.215641.


EWI-2 controls nucleocytoplasmic shuttling of EGFR signaling molecules and miRNA sorting in exosomes to inhibit prostate cancer cell metastasis.

Fu C, Zhang Q, Wang A, Yang S, Jiang Y, Bai L Mol Oncol. 2021; 15(5):1543-1565.

PMID: 33605506 PMC: 8096798. DOI: 10.1002/1878-0261.12930.


References
1.
Akhurst R, Hata A . Targeting the TGFβ signalling pathway in disease. Nat Rev Drug Discov. 2012; 11(10):790-811. PMC: 3520610. DOI: 10.1038/nrd3810. View

2.
Padua D, Massague J . Roles of TGFbeta in metastasis. Cell Res. 2008; 19(1):89-102. DOI: 10.1038/cr.2008.316. View

3.
Wang H, Sharma C, Knoblich K, Granter S, Hemler M . EWI-2 negatively regulates TGF-β signaling leading to altered melanoma growth and metastasis. Cell Res. 2015; 25(3):370-85. PMC: 4349253. DOI: 10.1038/cr.2015.17. View

4.
Perrot C, Javelaud D, Mauviel A . Insights into the Transforming Growth Factor-β Signaling Pathway in Cutaneous Melanoma. Ann Dermatol. 2013; 25(2):135-44. PMC: 3662904. DOI: 10.5021/ad.2013.25.2.135. View

5.
Scherf U, Ross D, Waltham M, Smith L, Lee J, Tanabe L . A gene expression database for the molecular pharmacology of cancer. Nat Genet. 2000; 24(3):236-44. DOI: 10.1038/73439. View